Adult Stem Cell Research Shows Promise|
Scientists sporting white coats and safety gloves are working in a bright Food and Drug Administration (FDA) lab on an incredible project. They are part of FDA’s MSC Consortium, a large team of FDA scientists studying adult mesenchymal stem cells (MSCs)-cells that could eventually be used to repair, replace, restore or regenerate cells in the body, including those needed for heart and bone repair. [U.S. Food and Drug Administration]
Orbsen Therapeutics In €6 Million Research Funding Success
Orbsen Therapeutics is Ireland’s leading Cell Therapy biotechnology company and is a spin-out from NUI Galway’s Regenerative Medicine Institute. MERLIN (MEsynchymal stem cells to Reduce Liver INflammation) will advance Orbsen’s proprietary cell therapy to a Phase IIa clinical trial in patients with inflammatory liver disease. [NUI Galway]
Bioheart Announces Clinical Study for Chronic Obstructive Pulmonary Disease
Bioheart, Inc. announced that it will enroll patients in a new study for chronic obstructive pulmonary disease (COPD). The study will enroll up to 100 patients to determine the safety and efficacy of adipose derived stem cells or AdipoCell™ in patients with COPD. [Bioheart, Inc.]
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!
Comments or Suggestions? Submit your feedback here.